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EDITORIAL
What can we learn from studies on regional differences in the utilization
of laboratory tests?
In this issue of Upsala Journal of Medical Sciences we
publish an interesting and highly novel article on the
use of laboratory tests in Spain (1).
The cost for health care has grown steadily over
the last 50 years. The yearly growth has been higher
than the growth of the gross domestic product
(GDP). Such growth cannot continue indeﬁnitely,
and we have over the last two decades seen diff-
erent ways of trying to limit the growth of health
care costs. This has resulted in a slight shift in the
aim of health care from the best care possible for the
patient to the best care possible for the patient at a
‘reasonable price’.
Today, we want as much health care as possible for
our citizens per spent euro, dollar, or whatever cur-
rency we are using. To be able to evaluate this, we
need to study the beneﬁts of different treatment
strategies and compare them with others. Usually,
this is analyzed in prospective studies that take
many years before we have any answers, and it is
rather costly. Another method could be to study
regional differences in clinical praxis and compare
them with outcome. An example of this is that the
surgeon hears about a new surgical technique and if it
is superior to the present one it is introduced at his/
her hospital. Such method transfers usually depend
on individuals and are not very systematic. In Sweden
and in many other countries quality registers are
developed to ﬁnd regional differences as a way of
improving health care. The disadvantage of the qual-
ity registers is that they are limited to a single country;
it would be even more interesting to compare different
countries as the differences are probably much larger
between countries than within.
The present Spanish study gives valuable insights
into the Spanish tradition of laboratory testing and
allows comparisons with the praxis at our own hospi-
tals (1). The cost of individual laboratory tests is
usually low, which may have contributed to the lim-
ited number of studies on the utilization of tests in
different countries. The role of laboratory tests has
evolved greatly over time, and the number of tests
has increased dramatically since the middle of the
last century. Presently, laboratory tests are used in
large numbers and are involved in 60%–70% of all
critical decisions such as admittance, discharge, and
medication (2).
Laboratory tests are ordered for many different
reasons, and some of the most common ones are for
deﬁnition of a diagnosis, assessment of disease sever-
ity, monitoring therapy, and detection of complica-
tions. It is important to remember that the goal of
laboratory testing is not the acquisition of informa-
tion per se but to improve the outcome for the
patient. There is no clear correlation between the
number of tests and the quality of care (3,4). Excess
test ordering has been reported to represent as much
as 30%–40% of all tests (5), and 20%–95% of selec-
ted tests (6). Thus, there are strong indications
that laboratory tests are overused, but they may
also be underused and misused. It is usually the
most frequently ordered laboratory tests that are
overused (7).
Spanish test-ordering patterns differ clearly from
what could be considered a ‘normal’ Swedish pattern
(8). It is easy to say that what we do in our own
hospital is correct and everything else is wrong
(regardless of whether we work in Spain or in
Sweden). For instance, from a Swedish perspective
the number of serum urate tests seems high in Spain,
and also serum iron is usually ordered without an
accompanying transferrin or total iron binding capac-
ity (TIBC) test. The Swedish tradition is to limit urate
tests mainly to patients with suspected gout and to
combine iron with transferrin/TIBC to allow calcula-
tion of iron saturation. It seems unlikely that the
number of gout patients is that much higher in Spain
than in Sweden. Does this mean that Spanish tradi-
tion is wrong? Not necessarily, as it could mean that
Spanish doctors use urate for other types of patients.
For instance, Spanish doctors may be using it as a
tumor marker. Urate increases with increased cell
turnover, and it is often increased in cancer patients.
It would be very interesting to know why Spanish
doctors order more urate tests. Patients in Spain and
Sweden should suffer from approximately the same
types of diseases. The difference between the two
countries shows that there is a suboptimal use of urate
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exploring the use of urate in both countries. I still
believe that iron should not be ordered without trans-
ferrin as in the Spanish study. Maybe I am wrong, but
I would still not recommend a change in Swedish test
use. Maybe both countries are wrong, and we should
use ferritin or soluble transferrin receptor instead of
iron, and transferrin when suspecting iron deﬁciency
anemia. Both iron and iron saturation have a clear
diurnal variation, which makes the interpretation of
test results difﬁcult if the patients come to the clinic at
other times than in the morning.
It could be argued that it is difﬁcult to deﬁne the
optimal use of speciﬁc laboratory markers, but the
differences shown in the Spanish study can be used
efﬁciently for discussions with local doctors on the use
of laboratory tests to change their ordering pattern.
We reduced AST requests from primary care doctors
signiﬁcantly by discussing the clinical value of the
marker. We could show that the hospital in Odense,
Denmark, had reduced the number of AST tests to
almost zero but there were no indications that patient
care in Odense was worse than in our county. The
conclusion from the comparison was that a lot of our
AST tests were redundant. The discussion led to a
signiﬁcant decrease in AST requests. According to
my experience, this type of discussion is much more
efﬁcient for changing ordering habits than using a
higher price or other types of pressure to change
ordering habits. Actually, we also tried doubling
the AST price as a means to reduce the number of
tests, but the effect of the cost increase was negligible.
It seems as if force only results in short-term changes
at best, and the request patterns usually return to
their original state within a few months. If we want to
create permanent changes we need continuous edu-
cation on the use of laboratory tests. Studies on
regional use of laboratory tests provide an excellent
base for this type of education.
Anders Larsson
Department of Medical Sciences, Uppsala University
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